A well-known mRNA vaccine is Pfizer's corona vaccine. Now a new type of RNA vaccine has been developed, the self-amplifying mRNA (SAM) vaccine. This type of vaccine not only produces the ...

Chimeron Bio aims to transform RNA therapy with its novel nanoparticle technology by developing new vaccines and therapies based on self-amplifying RNA for the treatment of infectious diseases ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...

With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Primrose Bio, Inc. ("Primrose"), a company developing proprietary therapeutic manufacturing technologies, announces the launch of Prima RNApols™ ExTend, an RNA polymerase engineered to significantly ...

Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA ...

SAN DIEGO--(BUSINESS WIRE)-- Arcturus Therapeutics Holdings Inc. (ARCT), a commercial messenger RNA medicine company ... Fast Track Designation for the self-amplifying mRNA (sa-mRNA) vaccine ...